Stem cell and induced pluripotent stem cell companies develop cells, therapies and research platforms capable of modelling development, disease and tissue regeneration. Their technologies support drug discovery, regenerative medicine, toxicology and advanced therapeutic development.
This category includes companies working on:
Browse 46 UK stem cell and iPSC companies below.
Authenticated cell lines, cell banking and culture testing services
ECACC is the European Collection of Authenticated Cell Cultures, a UK Health Security Agency resource based at Porton Down. It preserves and supplies quality-controlled human and animal cell lines, hybridomas, induced pluripotent stem cells and nucleic acids for biomedical research. Its services include cell line…
Automated cell culture systems and CDMO for cell therapy manufacturing
Mytos is a biotechnology company developing automated cell culture systems for pharmaceutical and biotechnology customers, replacing manual T-flask culture with closed, robotic instrumentation to improve reproducibility and scalability of human cell production. The platform serves drug discovery and clinical-stage…
Programmable iPSC cell therapies for cancer and autoimmunity
Xap Therapeutics is a Cambridge-based biotechnology company developing a synthetic biology platform for next-generation cell therapeutics. The company applies CRISPR technology to engineer induced pluripotent stem cells (iPSCs) into a universal "chassis" cell that can be functionalised with engineered receptors and…
High-purity animal-free growth factors and cytokines for cell culture
Qkine is a biotechnology company manufacturing recombinant growth factors and cytokines for stem cell, organoid and regenerative medicine research. Proteins are produced in E. coli using animal-free methods, with engineered variants available offering improved thermostability and extended bioactivity in culture. The…
Standardised mesenchymal stromal cell therapies for chronic tissue repair
TrophiCell develops cell therapies based on mesenchymal stromal cells, which release signals involved in tissue repair and immune regulation. Its patented production method aims to generate standardised cells at scale from a single donor, addressing variability associated with earlier cell therapy approaches. The…
Human iPSC-based safety and genotoxicity testing for gene therapy vectors
TestAVec is a provider of in vitro safety testing services for gene therapy and viral vector products, serving academic researchers and industry developers. The company's human stem cell based platform assesses vector-induced genotoxicity, evaluates patients' DNA repair capacity ahead of radiation or chemotherapy, and…